Annex

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance tulathromycin is replaced by the following:

Pharmacologically active Substance	Marker residue	Animal Species	MRL	Target Tissues	Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)	Therapeutic classification
‘Tulathromycin	(2R,3S,4R,5R,8R,10R,11R,12S, 13S,14R)-2-ethyl-3,4,10,13-tetra-hydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethy-lamino)-ß-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopent-decan-15-one expressed as tulathromycin equivalents	Bovine	300 μg/kg 200 μg/kg 4 500 μg/kg 3 000 μg/kg	Muscle Fat Liver Kidney	Not for use in animals from which milk is produced for human consumption Provisional MRLs expire on 1 January 2015	Anti-infectious agents/Antibiotics’
		Porcine	800 μg/kg 300 μg/kg 4 000 μg/kg 8 000 μg/kg	Muscle Skin and fat in natural proportions Liver Kidney	Provisional MRLs expire on 1 January 2015